Jade Biosciences Inc (NASDAQ:JBIO) has a beta value of -76.57% and has seen 238.82 shares traded in the last trading session. The company, currently valued at $9.11M, closed the last trade at $9.41 per share which meant it lost -$7.26 on the day or 9.89% during that session. The JBIO stock price is -43.46% off its 52-week high price of $13.50 and 51.43% above the 52-week low of $4.57. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.63 million shares traded. The 3-month trading volume is 8.96 shares.
Jade Biosciences Inc (NASDAQ:JBIO) trade information
Sporting 9.89% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the JBIO stock price touched $9.41 or saw a rise of 6.74%. Year-to-date, Jade Biosciences Inc shares have moved 63.92%, while the 5-day performance has seen it change 42.51%. Over the past 30 days, the shares of Jade Biosciences Inc (NASDAQ:JBIO) have changed 28.19%. Short interest in the company has seen 0.16 million shares shorted with days to cover at 0.85.
Wall Street analysts have a consensus price target for the stock at $16.5, which means that the shares’ value could jump 42.97% from current levels. The projected low price target is $14.0 while the price target rests at a high of $19.0. In that case, then, we find that the current price level is -101.91% off the targeted high while a plunge would see the stock gain -48.78% from current levels.
Jade Biosciences Inc (JBIO) estimates and forecasts
The company’s shares have gained 5.65% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -37.28% -77.98% over the past 5 years. Earnings growth for 2025 is a modest 95.66% while over the next 5 years, the company’s earnings are expected to increase by 64.67%.
JBIO Dividends
Jade Biosciences Inc is expected to release its next earnings report on 2025-Apr-25 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Jade Biosciences Inc (NASDAQ:JBIO)’s Major holders
Insiders own 0.04% of the company shares, while shares held by institutions stand at 30.90% with a share float percentage of 30.91%. Investors are also buoyed by the number of investors in a company, with Jade Biosciences Inc having a total of 111.0 institutions that hold shares in the company.
